Diplomat Specialty Pharmacy has appointed Jeanne Ann Stasny as VP pharmacy services, the company said Wednesday.
Sanofi has appointed David Meeker as CEO of Genzyme, the French drug maker said.
The Food and Drug Administration has approved a new drug for treating a severe form of epilepsy, the agency said Monday.
More than three-quarters of patients with multiple sclerosis using a drug made by Sanofi subsidiary Genzyme did not experience disease relapse for two years, according to results of a late-stage clinical trial revealed over the weekend.
Vertex Pharmaceuticals has filed for Food and Drug Administration approval of a drug for cystic fibrosis, the company said.
BioPlus Specialty Pharmacy has released a new video detailing the company's operations and introducing company executives.
Armada Health Care announced that its annual Armada Specialty Pharmacy Summit will feature Karl Rove and Robert Gibbs as keynote speakers.
Abbott on Wednesday morning announced plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
Teva Pharmaceutical Industries has completed its acquisition of another drug maker, following clearance from the Federal Trade Commission.
The Healthcare Distribution Management Association on Tuesday named six new members to its board of directors.